- Price
- $17.93
- Day
- +4.79%
- Mkt Cap
- $2.70B
- 52W Range
- $10.44 – $28.67
- Volume
- 2.26M
- Beta
- 1.43
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Shares of The Chemours Company (NYSE: CC - Get Free Report) have received an average rating of "Moderate Buy" from the twelve analysts that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, six have assigned a buy recommendation and
Read full article
Investors need to pay close attention to CC stock based on the movements in the options market lately.
Read full article
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read full article
Chemours (CC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
Fifth Third Bancorp increased its holdings in The Chemours Company (NYSE: CC) by 2,624.0% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,588 shares of the specialty chemicals company's stock after purchasing an additional 39,098 shares during
Read full article
A recovery in end-market demand and self-help measures, including cost cuts and productivity gains, position CC, MEOH, AVNT and DD to beat Q2 earnings estimates.
Read full article
Broker rating upgrades and robust earnings growth forecasts put PENN, CC and LITE in the spotlight as three stocks to buy now.
Read full article
WILMINGTON, Del., July 23, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its second quarter 2026 financial results after market on Tuesday, August 4, 2026.
Read full article
Annis Gardner Whiting Capital Advisors LLC acquired a new stake in shares of The Chemours Company (NYSE: CC) during the first quarter, according to its most recent disclosure with the SEC. The fund acquired 170,000 shares of the specialty chemicals company's stock, valued at approximately $3,745,000. Chemours makes up about 0.6% of Annis
Read full article
[url="]Interactive Brokers[/url] (Nasdaq: IBKR), an automated global broker, today announced the addition of nine new tokens for trading through zerohash and t
Read full article